GlassScriptPhysician profile
Robert L Shapiro
NPI 1982863700
$6,763.87
in general payments reported to CMS, 2019-2025
15 companies · $3,336 in 2025
The $3,336 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $12.50 · 2021: $45.75 · 2022: $276 · 2023: $1,313 · 2024: $1,469 · 2025: $3,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,077 · Travel and Lodging: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,076.60 |
| Travel and Lodging | $1,042.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,980.85 | 2019-2025 | Coronary Other, (Bq9) Coronary Ivus, Coronary Undivided |
| Heartflow, INC. | $1,402.05 | 2023-2025 | Ffrct |
| Boston Scientific Corporation | $929.78 | 2023-2025 | Watchman Access System, Watchman Flx |
| Medtronic, INC. | $533.49 | 2021-2025 | Symplicity G3, Onyx Frontier, Resolute Onyx |
| Recor Medical INC | $359.53 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Shockwave Medical, INC | $253.98 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $150.00 | 2024 | Impella |
| Edwards Lifesciences Corporation | $49.72 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Csl Behring | $37.67 | 2019 | |
| Cardiva Medical, INC. | $20.91 | 2024 | Optowire |
| Terumo Medical Corporation | $20.31 | 2022 | |
| Bracco Diagnostics INC. | $13.08 | 2023 | |
| Venclose INC. | $12.50 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.